O

OrbiMed Portfolio holdings

AUM $4.89B
1-Year Est. Return 87.75%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+87.75%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.91B
AUM Growth
+$840M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
159
New
Increased
Reduced
Closed

Top Buys

1
+$440M
2
+$270M
3
+$166M
4
ACET icon
Adicet Bio
ACET
+$95.1M
5
TBPH icon
Theravance Biopharma
TBPH
+$68.6M

Top Sells

1
+$119M
2
+$82.5M
3
+$64.2M
4
ALEC icon
Alector
ALEC
+$52.6M
5
GKOS icon
Glaukos
GKOS
+$46.5M

Sector Composition

1 Healthcare 98.49%
2 Financials 0.64%
3 Technology 0.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$470M 5.94%
+15,594,877
2
$353M 4.46%
7,406,307
3
$260M 3.29%
+7,330,423
4
$250M 3.16%
2,184,500
+28,500
5
$240M 3.03%
2,745,327
6
$234M 2.95%
3,008,755
+140,845
7
$219M 2.76%
6,645,100
8
$219M 2.76%
1,317,000
-7,100
9
$215M 2.71%
2,713,377
10
$214M 2.7%
3,549,100
+666,900
11
$203M 2.57%
715,900
12
$185M 2.34%
4,847,300
13
$181M 2.29%
666,100
14
$163M 2.06%
+5,477,958
15
$152M 1.93%
2,110,700
-1,129,814
16
$141M 1.78%
13,822,463
17
$137M 1.73%
4,673,850
18
$125M 1.58%
1,301,715
+115,800
19
$119M 1.5%
474,608
+1
20
$116M 1.47%
280,300
21
$113M 1.43%
734,500
-828,486
22
$105M 1.33%
3,426,325
23
$95.7M 1.21%
3,729,442
-275,000
24
$93.3M 1.18%
905,600
25
$92M 1.16%
6,219,110
+3,664,640
1
2 3 4 5